148 related articles for article (PubMed ID: 35348595)
1. DeepTTA: a transformer-based model for predicting cancer drug response.
Jiang L; Jiang C; Yu X; Fu R; Jin S; Liu X
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35348595
[TBL] [Abstract][Full Text] [Related]
2. Hi-GeoMVP: a hierarchical geometry-enhanced deep learning model for drug response prediction.
Chen Y; Zhang L
Bioinformatics; 2024 Mar; 40(4):. PubMed ID: 38614131
[TBL] [Abstract][Full Text] [Related]
3. DeepAEG: a model for predicting cancer drug response based on data enhancement and edge-collaborative update strategies.
Lao C; Zheng P; Chen H; Liu Q; An F; Li Z
BMC Bioinformatics; 2024 Mar; 25(1):105. PubMed ID: 38461284
[TBL] [Abstract][Full Text] [Related]
4. iBT-Net: an incremental broad transformer network for cancer drug response prediction.
Zhan Y; Guo J; Philip Chen CL; Meng XB
Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37429577
[TBL] [Abstract][Full Text] [Related]
5. DROEG: a method for cancer drug response prediction based on omics and essential genes integration.
Wu P; Sun R; Fahira A; Chen Y; Jiangzhou H; Wang K; Yang Q; Dai Y; Pan D; Shi Y; Wang Z
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36715269
[TBL] [Abstract][Full Text] [Related]
6. RefDNN: a reference drug based neural network for more accurate prediction of anticancer drug resistance.
Choi J; Park S; Ahn J
Sci Rep; 2020 Feb; 10(1):1861. PubMed ID: 32024872
[TBL] [Abstract][Full Text] [Related]
7. Learning the cellular activity representation based on gene regulatory networks for prediction of tumor response to drugs.
Xie X; Wang F; Wang G; Zhu W; Du X; Wang H
Artif Intell Med; 2024 Jun; 152():102864. PubMed ID: 38640702
[TBL] [Abstract][Full Text] [Related]
8. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
9. Predicting breast cancer drug response using a multiple-layer cell line drug response network model.
Huang S; Hu P; Lakowski TM
BMC Cancer; 2021 May; 21(1):648. PubMed ID: 34059012
[TBL] [Abstract][Full Text] [Related]
10. Predicting drug response of tumors from integrated genomic profiles by deep neural networks.
Chiu YC; Chen HH; Zhang T; Zhang S; Gorthi A; Wang LJ; Huang Y; Chen Y
BMC Med Genomics; 2019 Jan; 12(Suppl 1):18. PubMed ID: 30704458
[TBL] [Abstract][Full Text] [Related]
11. Improving anti-cancer drug response prediction using multi-task learning on graph convolutional networks.
Liu H; Peng W; Dai W; Lin J; Fu X; Liu L; Liu L; Yu N
Methods; 2024 Feb; 222():41-50. PubMed ID: 38157919
[TBL] [Abstract][Full Text] [Related]
12. Molecular data representation based on gene embeddings for cancer drug response prediction.
Park S; Lee H
Sci Rep; 2023 Dec; 13(1):21898. PubMed ID: 38081928
[TBL] [Abstract][Full Text] [Related]
13. GPDRP: a multimodal framework for drug response prediction with graph transformer.
Yang Y; Li P
BMC Bioinformatics; 2023 Dec; 24(1):484. PubMed ID: 38105227
[TBL] [Abstract][Full Text] [Related]
14. GraphCDR: a graph neural network method with contrastive learning for cancer drug response prediction.
Liu X; Song C; Huang F; Fu H; Xiao W; Zhang W
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34727569
[TBL] [Abstract][Full Text] [Related]
15. A Deep Learning Framework for Predicting Response to Therapy in Cancer.
Sakellaropoulos T; Vougas K; Narang S; Koinis F; Kotsinas A; Polyzos A; Moss TJ; Piha-Paul S; Zhou H; Kardala E; Damianidou E; Alexopoulos LG; Aifantis I; Townsend PA; Panayiotidis MI; Sfikakis P; Bartek J; Fitzgerald RC; Thanos D; Mills Shaw KR; Petty R; Tsirigos A; Gorgoulis VG
Cell Rep; 2019 Dec; 29(11):3367-3373.e4. PubMed ID: 31825821
[TBL] [Abstract][Full Text] [Related]
16. XGraphCDS: An explainable deep learning model for predicting drug sensitivity from gene pathways and chemical structures.
Wang Y; Yu X; Gu Y; Li W; Zhu K; Chen L; Tang Y; Liu G
Comput Biol Med; 2024 Jan; 168():107746. PubMed ID: 38039896
[TBL] [Abstract][Full Text] [Related]
17. Explainable drug sensitivity prediction through cancer pathway enrichment.
Tang YC; Gottlieb A
Sci Rep; 2021 Feb; 11(1):3128. PubMed ID: 33542382
[TBL] [Abstract][Full Text] [Related]
18. ITNR: Inversion Transformer-based Neural Ranking for cancer drug recommendations.
Sotudian S; Paschalidis IC
Comput Biol Med; 2024 Apr; 172():108312. PubMed ID: 38503090
[TBL] [Abstract][Full Text] [Related]
19. How much can deep learning improve prediction of the responses to drugs in cancer cell lines?
Chen Y; Zhang L
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34529029
[TBL] [Abstract][Full Text] [Related]
20. PANCDR: precise medicine prediction using an adversarial network for cancer drug response.
Kim J; Park SH; Lee H
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38487849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
